← Back to Search

Blood mangement group for Abnormal Uterine Bleeding

Q: What is the total enrollment number for this trial?

<p>Yes, according to clinicaltrials.gov the trial is still open for enrollment. The study was initially advertised on July 24th 2020 and has since been updated on July 11th 2022 with a need of 60 participants at 1 location.</p>

Q: Are researchers currently recruiting for this experiment?

<p>This clinical trial is presently recruiting participants, as evidenced by the information found on clinicaltrials.gov. The medical study was initially posted on July 24th 2020 and recently modified on July 11th 2022.</p>

N/A

Waitlist Available

Led By Rosanne Kho, M.D.

Research Sponsored by The Cleveland Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4-months

Awards & highlights

Study Summary

This trial is looking at whether or not blood management (planning ahead for blood transfusions, etc) before surgery can help reduce complications associated with blood transfusions after surgery, in patients undergoing surgery for fibroids or abnormal uterine bleeding.

Eligible Conditions

Abnormal Uterine Bleeding

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in hemoglobin level

Secondary outcome measures

Blood loss

Days on PO iron therapy

Intraoperative complications

+6 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Blood mangement groupExperimental Treatment1 Intervention

The intervention will include pre-surgical optimization blood management referral based on pre-operative Hgb levels <11.0. Treatment will include PO iron, IV iron, B12 or folate per blood management algorithm.

Group II: Usual careActive Control1 Intervention

Usual care per surgeon preference can include iron by mouth or no iron therapy.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The Cleveland ClinicLead Sponsor

1,026 Previous Clinical Trials

1,366,054 Total Patients Enrolled

1 Trials studying Abnormal Uterine Bleeding

68 Patients Enrolled for Abnormal Uterine Bleeding

Rosanne Kho, M.D.Principal InvestigatorThe Cleveland Clinic

1 Previous Clinical Trials

180 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total enrollment number for this trial?

"Yes, according to clinicaltrials.gov the trial is still open for enrollment. The study was initially advertised on July 24th 2020 and has since been updated on July 11th 2022 with a need of 60 participants at 1 location."

Answered by AI

Are researchers currently recruiting for this experiment?

"This clinical trial is presently recruiting participants, as evidenced by the information found on clinicaltrials.gov. The medical study was initially posted on July 24th 2020 and recently modified on July 11th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Role of Blood Management in Perioperative Outcomes

2020. "Role of Blood Management in Perioperative Outcomes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04475497.